title: [Medical treatment in abnormal uterine bleeding: evaluation of a GnRH therapy versus danazol therapy in perimenopausal women].
abstract: BACKGROUND
  Dysfunctional uterine bleedings are uterine hemorrhage, frequent in the climacteric period and are a usual gynecologic pathology in ambulatorial controls (10%).
  
  
  METHODS
  60 premenopausal women, have been enrolled, all affected by hyper-polymenorrhea or dysfunctional uterine bleeding; than they were subdivided them into 2 groups; Group I: 30 patients with GnRH analogues treatment (Decapeptyl da 3.75 mg/month, 6 months of therapy); Group II: 30 patients with Danazol treatment (danatrol, 200 mg/daily, 6 months of therapy). Clinical controls were performed by visit, a questionnaire compilation (Kuppermann index) and biochemical examinations, with this frequency: 0, 3, 6 and 9 months. Statistical evaluation was performed by Student "t" test.
  
  
  RESULTS
  In both groups, either amenorrohea and symptomatic improvement after 3 months of therapy were observed, without statistical differences; a statistical difference (p>0.01) was assessed in patients compliance, since were observed, without statistical differences a major frequency in collateral effects in II Group, with danazol therapy was observed. The results of this study show that, the limited occurrence of side effects in perimenopausal patients affected by dysfunctional uterine bleeding, treated with GnRH analogues, could affect the choice of pharmacological therapy in favor of these one.
authors.affiliation: Unità Operativa di Ostetricia e Ginecologia, Azienda Ospedaliera Vito Fazzi, Lecce, Italy. atinelli@blu.it
authors.forename: F G
authors.initials: FG
authors.lastname: Tinelli
authors.forename: A
authors.initials: A
authors.lastname: Tinelli
authors.forename: T
authors.initials: T
authors.lastname: Menis
authors.forename: R
authors.initials: R
authors.lastname: Tinelli
authors.forename: A
authors.initials: A
authors.lastname: Perrone
mesh_terms: D000328:Adult; D003613:Danazol / Q000627:therapeutic use*; D004965:Estrogen Antagonists / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008595:Menorrhagia / Q000188:drug therapy*; D008875:Middle Aged; D017329:Triptorelin Pamoate / Q000627:therapeutic use*
chemical_list: D004965:Estrogen Antagonists; D017329:Triptorelin Pamoate; D003613:Danazol